FDA Inspection 1210052 — Grifols d.b.a. Biomat USA, Inc.
The FDA completed an inspection of Grifols d.b.a. Biomat USA, Inc. on June 29, 2023 in Pueblo, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 29, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Pueblo, CO (United States)